Kitamura K, Kiyono H, Fujihashi K, Eldridge J H, Green D R, McGhee J R
Department of Microbiology, University of Alabama at Birmingham 35294.
J Immunol. 1987 Nov 15;139(10):3251-9.
Continuous gastric intubation of mice with the T cell-dependent antigen sheep erythrocytes (SRBC) leads to a state of systemic unresponsiveness to parenteral SRBC challenge, a state termed oral tolerance. The systemic unresponsiveness of mice rendered orally tolerant to SRBC, however, is converted to humoral immune responsiveness by adoptive transfer of effector T contrasuppressor (Tcs) cells. In this study, the authors have isolated and characterized the Tcs cell subset, from the spleens of orally immunized mice, which abrogates oral tolerance. This Tcs cell is a novel cell type, which can be separated from functional T suppressor (Lyt-2+) and T helper (L3T4+) cells, and the effector Tcs cell exhibits a Lyt-1+, 2-, L3T4- phenotype. Furthermore, contrasuppression is not mediated by B cells, including those of the Lyt-1+ phenotype. Adoptive transfer of splenic Lyt-1+, 2-, L3T4- T cells from C3H/HeJ mice given oral SRBC for 21 to 28 days and splenic Lyt-1+, 2-, L3T4- T cells of C3H/HeN mice orally immunized for a shorter interval abrogated oral tolerance. Furthermore, separation of Lyt-1+ T cells into L3T4+ and L3T4- subsets by flow cytometry resulted in Lyt-1+, L3T4+ T cells with helper but not contrasuppressor function, whereas the Lyt-1+, L3T4- T cell fraction abrogated oral tolerance even though it was without helper activity. This Tcs cell subset was also effective when added to cultures of tolerized spleen cells derived from SRBC-fed mice. The effector Tcs cells are antigen-specific, because Tcs cells from SRBC-immunized mice reverse tolerance to SRBC but not to horse erythrocytes (HRBC), and Tcs cells from HRBC-immunized mice reverse tolerance to HRBC but not to SRBC. When splenic T3 (CD3)-positive T cells (Lyt-1+, 2-, and L3T4-) were separated into Vicia villosa-adherent and nonadherent subpopulations, active contrasuppression was associated with the T3-positive and Vicia villosa-adherent T cell fraction. Thus, a distinct Lyt-1+, 2-, L3T4- T cell subset that contains a T3-T cell receptor complex, which can regulate oral tolerance, is present in spleens of orally immunized mice.
用T细胞依赖性抗原绵羊红细胞(SRBC)持续给小鼠进行胃插管,会导致对肠外SRBC攻击产生全身性无反应状态,这种状态称为口服耐受。然而,对SRBC产生口服耐受的小鼠的全身性无反应状态,通过效应T抗抑制细胞(Tcs)的过继转移可转变为体液免疫反应性。在本研究中,作者从口服免疫小鼠的脾脏中分离并鉴定了消除口服耐受的Tcs细胞亚群。这种Tcs细胞是一种新型细胞类型,可与功能性T抑制细胞(Lyt-2+)和T辅助细胞(L3T4+)分离,且效应Tcs细胞表现出Lyt-1+、2-、L3T4-表型。此外,抗抑制作用不是由B细胞介导的,包括那些Lyt-1+表型的B细胞。给C3H/HeJ小鼠口服SRBC 21至28天,其脾脏中Lyt-1+、2-、L3T4- T细胞的过继转移,以及对C3H/HeN小鼠进行较短时间口服免疫后其脾脏中Lyt-1+、2-、L3T4- T细胞的过继转移,均消除了口服耐受。此外,通过流式细胞术将Lyt-1+ T细胞分离为L3T4+和L3T4-亚群,结果显示Lyt-1+、L3T4+ T细胞具有辅助功能但无抗抑制功能,而Lyt-1+、L3T4- T细胞部分即使没有辅助活性也能消除口服耐受。当将这种Tcs细胞亚群添加到来自喂食SRBC小鼠的耐受脾细胞培养物中时也有效。效应Tcs细胞具有抗原特异性,因为来自SRBC免疫小鼠的Tcs细胞可逆转对SRBC的耐受,但不能逆转对马红细胞(HRBC)的耐受;而来自HRBC免疫小鼠的Tcs细胞可逆转对HRBC的耐受,但不能逆转对SRBC的耐受。当将脾脏中T3(CD3)阳性T细胞(Lyt-1+、2-和L3T4-)分离为绒毛野豌豆黏附性和非黏附性子群体时,活性抗抑制作用与T3阳性和绒毛野豌豆黏附性T细胞部分相关。因此,在口服免疫小鼠的脾脏中存在一种独特的Lyt-1+、2-、L3T4- T细胞亚群,其含有T3-T细胞受体复合物,可调节口服耐受。